Wendy Tate, PhD, GStat

This March, Insights Accrual Prediction platform was released to pilot customers. The second issue of our Q&A series continues our conversation with Dr. Wendy Tate, the author behind the machine learning tool’s algorithm, to hear her experience bringing this innovative tool to the research community and get her perspective on what comes next.

This March, Insights Accrual Prediction platform was released to pilot customers. We sat down with Dr. Wendy Tate, the author behind the machine learning tool’s algorithm, to learn what inspired her to tackle this industry hurdle and hear her experience bringing this innovative tool to the research community.

It is imperative that your organization has a reliable eRegulatory system and associated policies for storage and upkeep of clinical trial documents to ensure 21 CFR Part 11 compliance. Read our Key Considerations for Regulatory Compliant Document Storage.

Experts answer some of the most popular audience questions from the recent webinar The New Normal: Considerations for Restart Research. Read more:

If the clinical development time of a new treatment is to ever decrease, reducing the time in study activation is necessary so actual research can be done.

Research doesn’t just inform medical treatment; it informs public health and public policy, and it helps explain human behaviors. Read more:

Learn best practices of survey creation to help measure process improvement among stakeholders at an organization.

Learn what clinical trial performance metrics are, why they are important and which key metrics for clinical trials you should be measuring.